Comparison of Cold Atmospheric Plasma Devices' Efficacy on Osteosarcoma and Fibroblastic In Vitro Cell Models

Anticancer Res. 2017 Oct;37(10):5407-5414. doi: 10.21873/anticanres.11968.

Abstract

Background/aim: Cold atmospheric plasma (CAP) attenuates tumor cell proliferation and induces apoptosis in various cell lines. While exerting marginal effects on non-neoplastic cells this unfolds promising applications in cancer therapy. The aim of the study was to analyse the effects of different CAP sources and application times on osteosarcoma (OS) cells and non-malignant fibroblast cell proliferation.

Materials and methods: U2-OS and 3-T-3 fibroblasts were treated with three different approved medical devices. Carrier gas-treated cells served as controls. Cell proliferation was determined by viable cell count at different time points after treatment.

Results: Control exposed U2-OS and 3-T-3 cells exhibited characteristic cell growth. CAP application of U2-OS and 3-T-3 cells attenuated proliferation rates up to 98%. Attenuation rates varied between cell lines, plasma sources and application times.

Conclusion: CAP treatment attenuates cell proliferation of OS cancer cells and fibroblasts in a treatment time-dependent manner, whereby U2-OS cells appeared more sensitive to CAP treatment as 3T3 fibroblasts after 10 sec of treatment.

Keywords: Osteosarcoma; antitumor efficacy; apoptosis; cold atmospheric plasma.

Publication types

  • Comparative Study

MeSH terms

  • 3T3 Cells
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Equipment Design
  • Fibroblasts / drug effects*
  • Fibroblasts / pathology
  • Humans
  • Mice
  • Osteosarcoma / drug therapy*
  • Osteosarcoma / pathology
  • Plasma Gases / pharmacology*
  • Time Factors

Substances

  • Antineoplastic Agents
  • Plasma Gases